Entity

Novo Nordisk

Danish pharmaceutical company

Express your sentiment! Sign in!
Entity sentiment
1
Business
Novo Nordisk shares crash 24% after disastrous trial results
Novo Nordisk
Science
Zepbound defeats Wegovy in groundbreaking clinical trial
Fortune Novo Nordisk
Business
Defiance ETFs launches world's first leveraged ETF for Novo Nordisk
Novo Nordisk
Business
Money moves signal bearish sentiment on Novo Nordisk
Novo Nordisk
Science
Amgen's obesity drug shows promise with 20% weight loss after one year
Amgen Novo Nordisk Eli Lilly
Society
Quebecers Demand Greater Government Support for Obesity, October 2024
Novo Nordisk Mississauga
Business
FTC scrutinizes Novo Nordisk's $16.5B Catalent merger amid antitrust concerns
Novo Nordisk
Senate Hearing on High Ozempic and Wegovy Prices Scheduled
Bernie Sanders Novo Nordisk
Business
Eli Lilly Growing against Novo Nordisk
Novo Nordisk Eli Lilly
Business
Novo Nordisk Sees Big Sales Growth Despite Supply Issues
Novo Nordisk Denmark
Business
Novo Nordisk Lowers Forecast While Increasing Wegovy Production
Novo Nordisk
Business
Novo Nordisk Reports Lower Earnings and Cuts Profit Outlook
Novo Nordisk
Business
Eli Lilly Earnings Report: Wall Street Focuses on Zepbound Performance
Novo Nordisk Ozempic Eli Lilly
Business
Novo Nordisk Lowers Profit Forecast Due to Wegovy Sales Drop
Novo Nordisk
Business
Ozempic Boosts Denmark's Economy but Raises Concerns
Denmark Novo Nordisk
Novo Nordisk's Wegovy Gains EU Approval for Cardiovascular Use
Novo Nordisk European Union
Business
Study Links Semaglutide to Rare Eye Disease Risk
Novo Nordisk Harvard University
Health
Novo Nordisk invests $4.1 billion in North Carolina plant for weight loss and diabetes drugs production boost
Novo Nordisk
Health
The Wegovy weight loss drug was approved in China
People's Republic of China Novo Nordisk
Health
Fire outbreak at Novo Nordisk office is the third incident in a month
Novo Nordisk
Health
Bernie Sanders Calls for Reduction of Ozempic Drug Prices by Novo Nordisk
Bernie Sanders Novo Nordisk
Health
Gates, Novo Nordisk and Wellcome join forces with $300 million pledge
Wellcome Trust Novo Nordisk
Health
Novo Nordisk raises profit forecast for Wegovy as sales of weight-loss drug soar
Novo Nordisk
Business
A $6 billion investment in Ozempic, Wegovy was announced by Novo Nordisk
Novo Nordisk
Technology
Novo Nordisk owner invests millions in quantum computing
Novo Nordisk
Business
Thanks to this huge development, Novo Nordisk's stock could get another boost
Bernie Sanders Novo Nordisk
Technology
According to a study, Ozempic can be made for less than $5 a month
Novo Nordisk
Health
The weight loss pill could become a best in class drug according to the CEO
Novo Nordisk
Health
In a move that could expand insurance coverage, the FDA approved Wegovy for heart health benefits
Novo Nordisk Third Way
You've reached the end